NEW DELHI, INDIA--(Marketwire - Nov 1, 2012) - The drug manufacturers -- other industry, which features companies such as Teva Pharmaceutical Industries Limited and Allergan Inc., has been operating under complex conditions as of late. Patent expirations continue to negatively impact financials while research and development remains costly and time consuming. The Drug Manufacturers - Other industry has seen the above updates lately. And members can today access complimentary reports for two companies, Teva Pharmaceutical Industries Limited (
www.Street-Wire.com has brought together some of the best financial and technical minds from around the biggest economies globally so that you can have an array of free stock research and reporting. As the global economy continues to experience colossal strain and unprecedented actions are been taken by governments and the private sectors to survive and boost the dwindling worldwide economic growth, our researchers give you insight of how big players in different key sectors and industries of the American exchanges are faring. Sign up now for your free membership at
On the legal side of things, battles over patent infringement cases have led some companies higher while others have been dealt major setbacks. Settlement agreements have been popular, though the ultimate problem of loss of exclusivity is still a concern. Teva Pharmaceutical Industries Limited financial analysis available by signing up for free at
To counter some of the aforementioned headwinds, several companies in the industry have been expanding their operations abroad. Europe and Asia have been popular expansion destinations, though Latin America is also gaining in popularity. A number of companies have entered into strategic alliances with foreign companies that are already established abroad, which should make it easier for them to grow moving forward. Street-Wire.com posted financial analysis on Allergan Inc. today, members can access it at
Getting the necessary approvals for their products is another story though, and drug manufacturers that are able to team-up with foreign businesses while also getting their products to market could be best positioned.
Street-Wire aims to satisfy our new members with timely knowledge and to provide veteran traders with innovative and cognitive content when it comes to investing. We believe learning is a two-way channel, and we learn from our members as much as we provide them with what they need to make sense of the markets. We strive to introduce investors to new analytical viewpoint before the market becomes aware of them.
Read our Disclaimer
Anthony K. Merchant